# Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

> **NCT01273519** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 155 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01273519
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2014-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273519, "Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01273519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*